lingual glyceryl trinitrate (nitroglycerin), 40 Ag/kg, were studied on coronary blood flow and resistance, left ventricular (LV) pressures (P) and diameters (D), rate of change of pressure (dP/dt), (dP/dt)/P, and on the velocity (V) of myocardial fiber shortening in conscious dogs. Nitroglycerin i.v. caused substantial coronary vasodilatation prior to any changes in systemic hemodynamics. Mean coronary flow increased by a maximum of 47 ml/min and coronary sinus P02 rose from 16 to 26 mm Hg while pressure and diameter began to fall, and heart rate began to rise. After the maximal fall in mean arterial pressure (-26 mm Hg), a secondary peak in coronary flow occurred which was associated with increases in heart rate (100 beats/min), (dP/dt)/P (22%), and isolength V (12%). Beta blockade prevented the reflex increases in contractility but only a part of the reflex tachycardia; the remainder was prevented by cholinergic blockade. Maintaining heart rate constant minimized the decreases in LV D and increases in contractility. When the reflex inotropic and chronotropic effects were prevented by a combination of atrial pacing and beta blockade the early coronary vasodilatation was unaltered, but the later coronary vasodilatation was minimized. creases in contractility and heart rate. The decreases in diameter are largely the result of tachycardia. Sublingual nitroglycerin produced directionally similar, but quantitatively lesser effects on coronary flow and resistance, LV D, LV P, and contractility.
INTRODUCTION
Existing knowledge regarding the action of nitroglycerin on the normal myocardium and coronary vessels is based primarily on studies either in anesthetized open chest preparations or utilizing indirect techniques to assess coronary vasoactivity and myocardial contractility in conscious man (21) (22) (23) (24) (25) (26) . Since the drug elicits rapid changes in coronary and ventricular dynamics when administered intravenously, it is important to utilize methods which measure coronary blood flow, cardiac dimensions and pressures directly and instantaneously. Furthermore, the hypotensive effects of nitroglycerin elicit reflex increases in heart rate and myocardial contractility which would affect the coronary vessels secondarily and might obscure direct coronary vascular effects. Since anesthesia affects the coronary circulation (27) (28) (29) , depresses myocardial contractility (30) , and alters the normal coronary and myocardial responses to pharmacologic agents, such as cardiac glycosides (29) (30) , it is essential to describe the normal coronary and myocardial actions of cardiovascular therapeutic agents such as nitroglycerin in the conscious animal in which the complicating influences of anesthesia are absent. This is of particular importance since nitroglycerin reduces arterial pressure and thereby stimulates the baroreceptors, which exert differing effects in the presence and absence of general anesthesia (28, 31) . Accordingly, in the present investigation in order to clarify the effects of nitroglycerin on the normal coro-nary circulation and myocardium, the drug was administered to healthy, conscious dogs instrumented for direct and continuous measurement of coronary blood flow, arterial and left ventricular (LV)' pressures (P), left ventricular dimensions, rate of change of pressure (dP/ dt), and the velocity (V) of myocardial fiber shortening. In the first part of this study, a large dose of the drug was administered intravenously to provide a description of its pharmacologic properties and its reflex effects. In order to dissect the direct from the reflex effects of nitroglycerin, studies were conducted (a) when heart rate was maintained constant by electrical stimulation of the atria, and (b) after selective and combined beta adrenergic and cholinergic blockades. Finally since the drug is normally administered sublingually, the effects of sublingual were compared with i.v. administration. METHODS 15 mongrel dogs, weighing between 23 and 28 kg, were anesthetized with Na pentobarbital, 30 mg/kg. Through a thoracotomy in the fifth left intercostal space, miniature pressure gauges' were implanted within the left ventricle through a stab wound in the apex; opposing ultrasonic diameter transducers were sutured to the epicardium of the anterior and posterior walls of the left ventricle and Doppler ultrasonic flow transducers were placed around the left circumflex coronary artery and stimulator electrodes were sutured to the left atrium. Miniature pressure gauges2
were implanted in the thoracic aorta (three dogs) and heparin-filled tygon catheters were chronically implanted in the thoracic aorta (11 dogs). In two dogs diameter transducers were implanted on opposing endocardial surfaces of the left ventricle. In two dogs an electromagnetic flow transducer was placed on the left circumflex coronary artery. Heparin-filled tygon catheters were implanted in the coronary sinus during a subsequent right thoracotomy in three dogs anesthetized with Na pentobarbital, 30 mg/kg.
Both the miniature left ventricular and arterial pressure gauges (32) , were calibrated in vivo against a calibrated Statham P23 Db strain gauge manometer.' At autopsy the position of the ventricular gauges within the ventricular cavity was confirmed. In the eight dogs with previously implanted arterial catheters, arterial pressure was measured with a Statham P23Db strain gauge manometer. Left circumflex coronary blood flow was measured with an ultrasonic Doppler flowmeter (33, 34) in 10 dogs. This system which has been described in detail previously, has a reliable zero reference (33, 34) and in these experiments electrical zero blood flow was determined repeatedly and was confirmed by calibration when the animal was sacrificed. The relationship between velocity, as measured by the Doppler flowmeter, and volume flow is linear as long as the cross-sectional area of the blood vessel within the transducer remains constant. This linear relationship between velocity and volume flow has been confirmed by 'Abbreviations used in this paper: D, diameter; dD/dt, rate of change of diameter; dP/dt, rate of change of pressure; LV, left ventricular; P, pressure; V, velocity. 2Konigsberg P22, Konigsberg Instruments, Pasadena, Calif.
Construction details available from author. 4Statham Instruments, Inc., Oxnard, Calif. means of timed collections of blood flow (34) . At autopsy, it was observed that the vessels were firmly adherent to the flow transducers through a fibrous scar which minimized changes in the cross-sectional area of the vessel within the flow transducers. In two dogs an electromagnetic flowmeter (Statham SP2200)' was used to measure coronary blood flow. Zero flow in these experiments was obtained by inflation of a hydraulic occluder implanted distal to the flow transducer. An improved ultrasonic transit time dimension gauge was used to measure left ventricular diameter; 5 its principle of operation is similar to that of other ultrasonic gauges described previously (35, 36) The experiments were conducted three weeks to two months postoperatively, when the dogs had recovered from operation and were again vigorous and healthy. While the unsedated dogs were resting quietly, control records of left ventricular pressure, diameter, the time rate of change of diameter (dD/dt), i.e., the velocity of myocardial shortening, the rate of change of pressure, left circumflex coronary blood flow, arterial pressure, and heart rate were obtained. These variables were continuously recorded during all interventions until all measurements returned to the pre-nitroglycerin control levels. In nine dogs, glyceryl trinitrate (nitroglycerin), 40 Ag/kg, was administered intravenously in a bolus. This dose consistently resulted in marked and reproducible hemodynamic effects without causing any detectable discomfort to the conscious animal. If the animals showed any awareness of receiving the drug systemically or sublingually, the experiment was discarded. Seven of these dogs were also studied (a) with heart rate controlled by means of electrical stimulation of the atria at the peak frequency attained after a control injection of nitroglycerin, (b) after beta receptor blockade with propranolol, 1.0 mg/ kg, (c) after beta receptor blockade and with heart rate controlled at the frequency attained following nitroglycerin after beta receptor blockade, (d) after combined beta receptor blockade and cholinergic blockade with atropine 0.2 mg/kg, and (e) on a separate day before and after selective cholinergic blockade with atropine 0.2 mg/kg. The adequacy of beta blockade was tested with isoproterenol 1 Ag/ kg. In six dogs nitroglycerin, 40 ,g/kg, was dissolved in 1 cm3 tap water and placed sublingually both while the dogs were in sinus rhythm and after heart rate was controlled with atrial stimulation at the frequency attained following sublingual nitroglycerin in the control state. This was the smallest dose that consistently caused perceptible changes in systemic and coronary dynamics. The results of two responses to nitroglycerin in each state were averaged for each animal and analyzed statistically with standard errors and paired t tests (37 ?e recorder and signal from the pressure pulse, provided instantaneous and ph at a paper continuous records of heart rate. Electronic RC filters riggered by the having 2 sec time constants were used to derive mean arterial blood pressure and mean left circumflex coronary blood flow. Mean and late diastolic coronary resistances were calculated as the quotients of mean and late diastolic arterial pressures and coronary blood flows respectively. Continuous records of dP/dt and dD/dt were derived from the left ventricular pressure and diameter signals, using Philbrick operational amplifiers connected as differentiators.
A triangular wave signal with known slope (rate-of-change) was substituted for pressure and diameter signals to calibrate directly the dP/dt and dD/dt channels. The effects of nitroglycerin on myocardial force-velocity relations were assessed by determining their effects on the velocity of shortening and intraventricular pressure at an identical ventricular diameter (isolength point), by the technique described in detail previously (30, 31, 38) . All isolength points were obtained during the first one-third of ejection. In addition, the effects on peak dP/dt and the quotient of dP/dt and developed pressure (left ventricular isovolumic minus end diastolic pressure) i.e., (dP/dt)/P, were examined. The same level of pressure which occurred '~; --4~~4 during isometric contraction, before and after each intervention, was used for this calculation and dP/dt and P were determined at that level of pressure. This technique for evaluating the myocardial contractile state has been PEAK described in detail previously (30, 31, 39, 40 Heart rate. After the decline in arterial pressure, heart rate rose from 75±4 to a maximum of 175+8 beats/min. The maximum increase in heart rate occurred after the peak hypotensive effects, C, but before the peak inotropic effects, D, of nitroglycerin (Fig. 2) .
Pressure. Mean arterial pressure decreased following nitroglycerin, falling to a minimum level of 70±3 mm Hg at point C from a control of 96±2 mm Hg (Fig. 2 ) and returned to control by 159±+12 sec after i.v. injection of nitroglycerin. Peak LV systolic pressure followed a similar pattern, decreasing from 130±5 to 111±4 xnm Hg. LV end diastolic pressure fell from 8±1 to 2±1 mm Hg, gradually returning to control by 3 min after the administration of nitroglycerin, which was slightly later than the return of systolic LV P and mean' arterial pressure.
Coronary bed. Nitroglycerin increased mean left circumflex coronary flow before any detectable changes in arterial or ventricular pressures, heart rate, left ventricular dimensions, or contractility (Fig. 3) . At this point, A, mean coronary flow had risen from 38+2 to 63±2 ml/min and mean coronary resistance had decreased from 2.56±0.09 to 1.52+0.05 mm Hg/ml per min. Mean coronary flow reached a maximum of 85±3 ml/ min, while mean coronary resistance fell to a minimum of 1.02±0.04 mm Hg/ml per min (B). Mean coronary flow declined slightly with maximal decrease in arterial pressure (C) and then reached a secondary peak of 69±6 ;ml/min associated with the reflex changes in heart rate and contractility (D) and then gradually returned to control. Although the increases in late diastolic coronary flow and decreases in late diastolic resistance were slightly less when pressure fell (Fig. 2) (Fig. 2) . End diastolic and systolic diameters began to return to control when pressure increased, and were still slightly reduced when pressure had returned to control. In the one dog in which it was measured internal end diastolic and systolic diameters decreased by 4.3 and 3.3 mm, respectively, from control values of 38.4 and 28.5 mnm, respectively. Myocardial contractile state. Although peak dP/dt fell slightly with pressure, (dP/dt)/P did not show a significant change in the early responses, (A-C) but increased at point D by 22±2% above a control of 43±2 sec' (Fig. 2) . At the time of maximal increase in (dP/dt)/P, isolength velocity had also increased, by 17±2% from a control of 62±4 mm/sec. At this point isolength systolic left ventricular pressure was slightly reduced, 122+ 4 mm/Hg as compared with a control of 125±4 mm/Hg.
Arterial and coronary venous oxygen. In three dogs simultaneous arterial and coronary sinus oxygen determinations were made before drug administration, and during the early (B) and later (D) periods of coronary vasodilatation. In all determinations in all three animals nitroglycerin did not alter arterial oxygen tension but increased coronary sinus Po2 from 16±1 to 26+2 sum Hg during the early response, i.e., at point B, and then coronary sinus Po, declined to 19±2 mm Hg, at point D, during the later period of coronary vasodilatation (Fig. 4) .
Effects of i.v. nitroglycerin, 40 /ug/kg, after reflex effects prevented
Heart rate. Beta receptor blockade did not significantly affect resting heart rate, but following nitroglycerin, the rate increased from 75±3 to only 125+5 beats/ min. Cholinergic blockade increased heart rate to 173±11 beats/min and nitroglycerin increased it further to 209±8 beats/min. After combined beta and cholinergic blockades heart rate did not change significantly following nitroglycerin. Thus, the effects of nitroglycerin on heart rate appear to be induced reflexly and the tachycardia is mediated by both the sympathetic and parasympathetic nervous systems.
Pressure. The changes in systolic LV P or mean arterial pressure induced by nitroglycerin were not substantially different when heart rate was maintained constant or after beta or cholinergic blockade, but the fall in end diastolic pressure was less when the rise in heart rate was reduced.
Coronary bed. When nitroglycerin was administered with heart rate maintained constant at 175+8 beats/min, the early (A) and peak (B) effects on coronary flow were not substantially different but the later effects (C and D) were somewhat reduced. After beta receptor blockade, and when heart rate was maintained constant at 125±+5 beats/mmin, nitroglycerin still increased coronary flow and decreased coronary resistance initially (A and B), but the secondary peak in coronary flow (D) was not observed (Fig. 5) , and both coronary flow and resistance returned to control earlier. Coronary resistance returned to control by 94±8 sec as compared with 156±17 sec in the control state (Fig. 6) 5 The normal responses (solid lines) and those following beta blockade and heart rate held constant with atrial pacing (broken lines) are compared following i.v. nitroglycerin, 40 uag/kg, on mean coronary flow and resistance, (dP/dt)/P, isolength velocity, and heart rate. Note that preventing reflex effects does not substantially affect the early or peak coronary effects but modifies the later coronary response.
glycerin as occurred following beta blockade with heart rate constant. Thus, nitroglycerin causes two phases of coronary vasodilatation the first is primarily direct, while the second is primarily due to reflex increases in heart rate and myocardial contractility (Fig. 6) .
Left ventricular dimensions. When heart rate was held constant either in the control state or after beta blockade, the reduction in external or internal diameters with nitroglycerin was substantially attenuated (Fig. 7) . nitroglycerin was due mainly to the tachycardia that occurred and to a lesser extent to the peripheral effects. Myocardial contractile state. When heart rate was maintained constant but prior to autonomic blockade the later increases (D) in (dP/dt)/P was only 17±3% from a control of 42±3 sec' (Fig. 7) . This was slightly but significantly less (P < 0.01) than the response in spontaneous rhythm (22±2%). After beta blockade and with heart rate constant, (dP/dt)/P did not increase after the decline in pressure with nitroglycerin. When heart rate was maintained constant, although isolength . NEF""" pressure had decreased by a similar amount, the increase in isolength velocity was only 10±1% from a control of 56±4 mm/sec, which was less (P < 0.05) than occurred when heart rate was allowed to vary (17±2%).
A similar response was observed in the one dog in which velocity was derived from the measurement of internal diameter. After beta blockade, and with heart rate constant, isolength velocity did not increase. Thus, the increase in myocardial contractility after the decline in arterial pressure was slightly less when heart rate was maintained constant but was primarily due to activation of myocardial beta receptors.
Effects of sublingual nitroglycerin, 40,ug/kg, (Table I) Spontaneous rhythm (six dogs (Table I) . A slight positive inotropic effect was observed: (dP/dt)/P increased by 9±1% sec1, while isolength velocity increased by 12±2%. Mean coronary flow rose slightly, by only 10±1 m/min, and mean coronary resistance declined by 0.71+±0.6 mm Hg/ml per min. The peak increase in coronary flow and decrease in coronary resistance occurred at the time of maximal reduction in pressures and cardiac dimensions (average = 2 min). All these changes with sublingual nitroglycerin were significant (Table I ), but were significantly less (P < 0.01) than those observed when the drug was administered intravenously (Fig. 7) . Paced (six dogs). When heart rate was maintained constant at 114±5 beats/min, the changes in mean arterial and LV systolic pressures were similar to those occurring when heart rate was allowed to vary spontaneously, but the reductions in both end diastolic (-0.4±0.1 mm) and end systolic (-0.4±0.1 mm) diameters were significantly less (P < 0.01), and the increases in (dP/dt)/P and isolength velocity were not observed (Fig. 7) . The rise in mean coronary flow, 5±1 ml/min, and the decrease in coronary resistance, 0.43±.05 mnu Hg/ml per min, were also less (P < 0.01).
DISCUSSION
In the present investigation nitroglycerin was found to be a potent primary coronary vasodilator in the healthy, conscious dog. The evidence for this is threefold. First, i.v. nitroglycerin caused a striking increase in coronary blood flow and reduction in coronary resistance before changes in heart rate, arterial pressure, ventricular di-,mensions, or myocardial contractility (Figs. 1, 3) . Second, the early and peak coronary vasodilator effects were not materially affected by preventing the reflex effects with beta adrenergic blockade and maintaining heart rate constant (Fig. 5) . Finally, the coronary vasodilatation was associated with an increase in coronary sinus oxygen and a narrowing of coronary A-Vo, difference (Fig.  4) . In addition nitroglycerin resulted in a later period of coronary vasodilatation, which was associated with increases in heart rate and myocardial contractility and much less of an increase in coronary sinus oxygen. Thus, i.v. nitroglycerin causes two phases of coronary vasodilatation in the conscious dog; the first phase is due to a direct effect on the coronary vessels, while the latter is (Fig. 7) . Sublingual nitroglycerin in the presence of a constant heart rate was not associated with increases in (dP/dt)/P or isolength velocity but coronary resistance fell slightly (20%), indicating that even when administered sublingually at a dose which produced changes in systemic hemodynamics similar to those reported for man (21) (22) (23) 41) , a distinct direct effect on the coronary vessels could be identified. Considering the minor rise in coronary flow and the moderate extent of coronary vasodilatation, it is not surprising that prior studies utilizing indirect techniques (22, 24, 42, 43) or studies in open chest preparations in which the coronary bed may already have been partially dilated by the effects of anesthesia and surgery (4, 8, 9) could not identify an effect due to sublingual nitroglycerin. If in the present investigation only coronary flow had been measured following sublingual nitroglycerin, when the increases in rate and contractility were prevented by atrial stimulation, it would be concluded that nitroglycerin has a negligible effect on the coronary bed. However, since arterial pressure fell, a significant reduction in coronary resistance occurred, indicating that sublingual nitroglycerin exerts a moderate vasodilating action on the normal coronary bed, even when heart rate and contractility remain constant. Similarly, Rowe et al. (43) and Hollander et al. (44) found that although coronary blood flow did not increase with nitrites, arterial pressure decreased, resulting in a decline in calculated coronary resistance in patients with coronary artery disease.
Since anesthesia can radically alter neural control of the circulation (28, 31) , it is understandable that many of the previous studies did not note a reflex increase in contractility following the hypotensive effects of i.v. nitroglycerin (5, 7, 15, 17) . Some studies even failed to find substantial increases in heart rate (14, 16) . Since both of these effects stimulate myocardial metabolism, and thereby augment coronary blood flow (45) (46) (47) it follows that nitroglycerin administered to anesthetized preparations with an open chest, does not elicit a secondary rise in coronary blood flow and reduction in coronary resistance (8) (9) (10) 14) .
In the healthy conscious dog, in which the effects of anesthesia are absent and all control mechanisms are intact, i.v. nitroglycerin elicited large reflex increases in heart rate (100 beats/min) and a modest reflex increase in the myocardial contractile state (dP/dt)/P rose by 22%). Both of these effects were much less when nitroglycerin was administered sublingually and in fact the small increases in velocity and (dPdt)/P were not observed when heart rate was maintained constant by atrial stimulation (Fig. 7) . Similarly, the reflex effects on contractility after i.v. administration were slightly but significantly less when heart rate was not allowed to rise (Fig. 7) . This could not be explained on the basis that simple tachycardia increased contractility, since the control level of velocity and (dP/dt)/P were actually less at the higher rate. Moreover, we have recently observed that elevating heart rate at rest in conscious dogs with atrial pacing does not increase myocardial contractility (48) . It may be that cardiac receptors are partially responsible for the afferent arc of the reflex inotropic effects (49, 50) ; a reduction in cardiac size stimulating a reflex increase in contractility. When heart rate was allowed to vary, nitroglycerin reduced ventricular size substantially, but when heart rate was maintained constant, the effects on ventricular size were substantially less. Thus, a reflex increase in contractility induced by a decrease in cardiac size would be considerably attenuated by maintaining heart rate constant. It is important to note that a negative inotropic effect was not observed, when the drug was administered either intravenously or sublingually, since some groups have proposeda negative inotropic effect of the drug, either direct (5, 7, 16, 17) or due to an adrenergic blocking effect (15, 18) .
Although it is recognized that nitroglycerin causes ventricular size to diminish (19, 20, 25, 26, 51, 52) it is not generally appreciated that the reduction in size is due predominantly to the associated tachycardia. Although this effect was observed when the drug was given intravenously it was even more apparent after sublingual administration (Fig. 7) .
In conclusion, the present investigation demonstrates a number of important features not generally appreciated of the action of nitroglycerin on the normal heart and coronary vessels. I.v. nitroglycerin in the conscious dog produces two phases of coronary dilatation; the first phase is due to a direct effect on the coronary vessels while the later phase is associated with changes in cardiac size, rate, and contractility. A negative inotropic effect was not observed, but a reflex increase in contractility occurred. At a constant heart rate, the decreases in ventricular dimensions are substantially diminished and the reflex increase in contractility is reduced. Sublingual nitroglycerin produces directionally similar but quantitatively lesser and more prolonged effects than i.v.
nitroglycerin, and at a constant heart rate, the reduction in left ventricular end diastolic size was less, no effect on contractility was observed, but coronary flow still increased slightly and distinct reduction in coronary resistance occurred.
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